Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The treatment was effective for lupus nephritis with manageable side effects.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The combination therapy effectively treats infertility in PCOS without major side effects.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Depo-Provera effectively prevents pregnancy but has many side effects and safety concerns, leading to its ban in the U.S.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.